Print Page   |   Contact Us   |   Your Cart   |   Sign In   |   Join
Journal CPE Programs
Share |

 

Journal CPE Programs

In order to process your CE credits, you must provide us with your correct NABP e-Profile ID number and your birth month and day (MMDD format). The NABP e-Profile ID number is a six to 10 digit number, and it is NOT your license number or NPI number.  If you need to verify the number or have not yet registered for one, please visit www.MyCPEMonitor.net as soon as possible.

Prebiotics, Probiotics, and Synbiotics: Their Therapeutic Role (expires 8-15-19)

A New Generation of Medical Errors with the Rise of Health Information Technology
 (expires 7-15-19)

New Drugs: Corlanor, Entresto, Vraylar, Rexulti
(expires 6-15-19)

Naloxone: Overview and Resources for Pharmacists (expires 5-15-19)

New Prescription Labeling Requirements for the Use of Medications in Pregnancy and Lactation
(expires 4-15-19)

Pneumococcal Disease: Treatment and Prevention
(expires 3-15-19)

Update on Cholesterol Treatment and Two New Drugs: Praluent and Repatha
(expires 2-15-19)

Management of Diarrhea-predominant Irritable Bowel Syndrome with Focus on Viberzi and Xifaxan (expires 1-15-19)

An Update on Smoking Cessation: Treatments and Electronic Cigarettes
(expires 12-15-18)

New Drugs: Cosentyx, Ibrance, Lenvima, and Unituxin (expires 11-15-18)


New Drugs: Beleodaq, Belsomra, Jardiance, and Zydelig (expires 5-15-18)

 

Mental Illness Counseling: Communication Strategies and Resources for Pharmacists (expires 4-15-18)

New Drugs: Dalvance, Entyvio, Jublia, and Zontivity (expires 3-15-2018)

Heartfailure: Updated Treatment Guidelines (expires 2-15-2018)

New Drugs: Cyramza, Sylvant, Tanzeum, and Zykadia (expires 1-15-2018)


Parkinson's Disease: Non-Pharmacological Interventions
(expires 11-15-17)

Parkinson's Disease: Improving Symptom Control with Pharmacotherapy (expires 10-15-17)


New Drugs: Impavido, Myalept, Neuraceq, and Otezla
(expires 9-15-17)


Obesity: Treatment Guidelines and Update on Use of Belviq and Qsymia
(expires 8-15-17)


New Drugs: Farxiga, Hetlioz, Northera, and Vimizim (expires 7-15-17)


New Drugs: Aptiom, Imbruvica, Luzu, and Sovaldi (expires 6-15-17)


Atypical Antipsychotics: Overview, Metabolic Abnormalities, and Newer Agents (expires 5-15-17)


Advances in the Treatment of Pulmonary Hypertension: Focus on Adempas and Opsumit (expires 4-15-17)


Acute Bacterial Skin and Skin Structure Infections: Review and Update (expires 3-15-17)


Vitamin D Deficiency and Treatment (expires 2-15-17)

New Drugs: Gazyva, Gilotrif, Perjeta, and Tivicay (expires 1-15-17)

Therapeutic Actions and the Genetic Code: Examples of the Aplication of Pharmacogenetics (expires 12-15-16)

FDA Safety Warnings and Prescribing Updates: Zolpidem, Valproate, Ketoconazole, and Acetaminophen (expires 11-15-16)

Melanoam-Targeted Therapy: Focus on Mekinist and Tafinlar (expires 10-15-16)

more Calendar

9/28/2016
Webinar: Collaborative Practice Agreements For Pharmacists In Today’s Health Care Environment

10/1/2016
Technician Day Spokane

10/6/2016
WSPA Board of Directors Meeting

Online Surveys
1402 - ICU Medical Inc Campaign
Association Management Software Powered by YourMembership.com®  ::  Legal